Daxor Will Exhibit Blood Platform in Denver
The company will display its FDA-cleared diagnostic technology at the 59th annual ASN Kidney Week in October.
Updated on Oct. 13, 2026 in Healthcare
Live Poll
Should medical companies prioritize precision diagnostic technology to improve outcomes for local kidney patients?
Daxor Corporation will demonstrate its blood volume analysis platform at the 59th annual ASN Kidney Week, scheduled for October 21-25, 2026. The event will take place at the Colorado Convention Center in Denver.
Why it matters
The company intends to engage with international leaders in nephrology to promote precision medicine for renal care. This participation aligns with corporate goals to accelerate market expansion for their diagnostic technology.
Daxor operates from a 20,000-square-foot manufacturing facility and brings 50 years of innovation to the conference. Attendees can find them at Booth #390.
The players
Daxor Corporation
A publicly traded Nasdaq company that specializes in blood volume analysis instrumentation.
ASN Kidney Week
The 59th annual meeting of the American Society of Nephrology, which brings together specialists in renal health.
The details
Daxor representatives will offer live overviews of the platform, which provides measurements for total blood, red blood cell, and plasma volume. They will also provide information regarding reimbursement pathways for healthcare providers on-site.
Timeline
Daxor will exhibit at ASN Kidney Week 2026 from October 21-25, 2026.
Market Landscape
This move highlights the ongoing corporate effort to integrate specialized diagnostic tools into the broader nephrology care model. It positions Daxor to compete by engaging directly with global decision-makers in the renal health sector.
Healthcare providers attending the conference can receive direct guidance on reimbursement pathways for blood volume testing. This engagement aims to eventually improve precision diagnostics available for patients managing kidney disease.
The takeaway
Clinicians and researchers may find value in reviewing new diagnostic workflows presented at large-scale industry meetings. Implementing precise blood volume metrics can be a significant step in managing care for patients with complex renal conditions.
Further reading
Learn more about the latest innovations in Healthcare.
Source note: This article includes information reported by The Manila times.
Live Poll
Should medical companies prioritize precision diagnostic technology to improve outcomes for local kidney patients?
